A Critical Note on Treatment of a Severe Diltiazem Intoxication: High-Dose Calcium and Glucagon Infusions

Mathilde Van Veggel1, Gijs Van der Veen2, Tim Jansen2,3

  • 1Department of Pharmacy, Franciscus Gasthuis Hospital, Rotterdam, The Netherlands.

Insights

Severe diltiazem intoxication can be life-threatening, causing cardiac issues. High-dose calcium and glucagon infusions may help, but careful monitoring is crucial to avoid complications like pancreatitis.

Area of Science:

  • Cardiology
  • Toxicology
  • Emergency Medicine

Background:

  • Severe calcium channel blocker intoxication presents significant morbidity and mortality.
  • Treatment options are supported by limited, low-quality evidence.
  • Diltiazem intoxication specifically can lead to severe cardiac toxicity.

Observation:

  • A case of severe diltiazem intoxication in a 53-year-old woman presenting with cardiogenic shock and complete AV block is described.
  • The patient did not respond to standard treatments including atropine, isoprenaline, and external pacing.
  • Initial treatment involved fluids, inotropes, vasopressors, high-dose calcium, and glucagon infusions.

Findings:

  • The patient's condition improved with high-dose calcium and glucagon infusions.
  • However, she developed acute necrotizing pancreatitis, likely due to iatrogenic hypercalcemia.
  • There is a lack of consensus on target serum calcium levels for treating diltiazem intoxication.

Implications:

  • Goal-directed calcium tapering is essential to prevent side effects like hypercalcemia.
  • The efficacy of glucagon infusions is questionable due to the instability of solubilized glucagon, potentially explaining variable treatment outcomes.
  • This case highlights the need for further research into optimal treatment strategies for severe calcium channel blocker overdoses.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.7K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.4K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.6K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.8K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
86